Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report

被引:44
作者
Basilious, Alfred [1 ]
Lloyd, John C. [1 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
来源
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE | 2016年 / 51卷 / 01期
关键词
MELANOMA; ANTI-PD-1; SAFETY; PD-1;
D O I
10.1016/j.jcjo.2015.09.008
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:E4 / E6
页数:4
相关论文
共 9 条
[1]   PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells [J].
Blank, C ;
Brown, I ;
Peterson, AC ;
Spiotto, M ;
Iwai, Y ;
Honjo, T ;
Gajewski, TF .
CANCER RESEARCH, 2004, 64 (03) :1140-1145
[2]   Risk of Hypotony in Noninfectious Uveitis [J].
Daniel, Ebenezer ;
Pistilli, Maxwell ;
Pujari, Siddharth S. ;
Kacmaz, R. Oktay ;
Nussenblatt, Robert B. ;
Rosenbaum, James T. ;
Suhler, Eric B. ;
Thorne, Jennifer E. ;
Foster, C. Stephen ;
Jabs, Douglas A. ;
Levy-Clarke, Grace A. ;
Kempen, John H. .
OPHTHALMOLOGY, 2012, 119 (11) :2377-2385
[3]   The PD-1 pathway in tolerance and autoimmunity [J].
Francisco, Loise M. ;
Sage, Peter T. ;
Sharpe, Arlene H. .
IMMUNOLOGICAL REVIEWS, 2010, 236 :219-242
[4]   Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma [J].
Hamid, Omid ;
Robert, Caroline ;
Daud, Adil ;
Hodi, F. Stephen ;
Hwu, Wen-Jen ;
Kefford, Richard ;
Wolchok, Jedd D. ;
Hersey, Peter ;
Joseph, Richard W. ;
Weber, Jeffrey S. ;
Dronca, Roxana ;
Gangadhar, Tara C. ;
Patnaik, Amita ;
Zarour, Hassane ;
Joshua, Anthony M. ;
Gergich, Kevin ;
Elassaiss-Schaap, Jeroen ;
Algazi, Alain ;
Mateus, Christine ;
Boasberg, Peter ;
Tumeh, Paul C. ;
Chmielowski, Bartosz ;
Ebbinghaus, Scot W. ;
Li, Xiaoyun Nicole ;
Kang, S. Peter ;
Ribas, Antoni .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :134-144
[5]   Retinal vasculitis and ocular vitreous metastasis following complete response to PD-I inhibition in a patient with metastatic cutaneous melanoma [J].
Manusow, Joshua S. ;
Khoja, Leila ;
Pesin, Nataly ;
Joshua, Anthony M. ;
Mandelcorn, Efrem D. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2014, 2
[6]   PD-1 and PD-1 ligands: from discovery to clinical application [J].
Okazaki, Taku ;
Honjo, Tasuku .
INTERNATIONAL IMMUNOLOGY, 2007, 19 (07) :813-824
[7]   Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial [J].
Robert, Caroline ;
Ribas, Antoni ;
Wolchok, Jedd D. ;
Hodi, F. Stephen ;
Hamid, Omid ;
Kefford, Richard ;
Weber, Jeffrey S. ;
Joshua, Anthony M. ;
Hwu, Wen-Jen ;
Gangadhar, Tara C. ;
Patnaik, Amita ;
Dronca, Roxana ;
Zarour, Hassane ;
Joseph, Richard W. ;
Boasberg, Peter ;
Chmielowski, Bartosz ;
Mateus, Christine ;
Postow, Michael A. ;
Gergich, Kevin ;
Elassaiss-Schaap, Jeroen ;
Li, Xiaoyun Nicole ;
Iannone, Robert ;
Ebbinghaus, Scot W. ;
Kang, S. Peter ;
Daud, Adil .
LANCET, 2014, 384 (9948) :1109-1117
[8]   Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma - A new cause of uveitis [J].
Robinson, MR ;
Chan, CC ;
Yang, JC ;
Rubin, BI ;
Gracia, GJ ;
Sen, HN ;
Csaky, KG ;
Rosenberg, SA .
JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) :478-479
[9]   Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer [J].
Topalian, Suzanne L. ;
Hodi, F. Stephen ;
Brahmer, Julie R. ;
Gettinger, Scott N. ;
Smith, David C. ;
McDermott, David F. ;
Powderly, John D. ;
Carvajal, Richard D. ;
Sosman, Jeffrey A. ;
Atkins, Michael B. ;
Leming, Philip D. ;
Spigel, David R. ;
Antonia, Scott J. ;
Horn, Leora ;
Drake, Charles G. ;
Pardoll, Drew M. ;
Chen, Lieping ;
Sharfman, William H. ;
Anders, Robert A. ;
Taube, Janis M. ;
McMiller, Tracee L. ;
Xu, Haiying ;
Korman, Alan J. ;
Jure-Kunkel, Maria ;
Agrawal, Shruti ;
McDonald, Daniel ;
Kollia, Georgia D. ;
Gupta, Ashok ;
Wigginton, Jon M. ;
Sznol, Mario .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2443-2454